CLBT
Cellebrite DI
11.10$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.5% | 79.2% | 70.5% | 74.5% | 79.7% | 82.2% | 73.7% | 77.0% | 80.1% | 61.3% | 56.2% | 58.7% | |
| 28.7% | 35.6% | 23.1% | 19.2% | 21.7% | 27.8% | 12.7% | 22.8% | 33.7% | 13.3% | 14.0% | 14.2% | |
| 55.3% | 56.8% | 52.3% | 54.9% | 58.9% | 64.8% | 57.7% | 60.0% | 63.0% | 46.6% | 45.1% | 44.5% | |
| 14.6% | 14.5% | 11.6% | 12.7% | 14.9% | 11.9% | 11.4% | 11.8% | 12.5% | 11.2% | 7.6% | 11.1% | |
| 2.4% | 1.9% | 1.7% | 1.6% | 1.5% | 1.3% | 1.3% | 1.2% | 1.0% | 0.8% | 0.8% | 0.8% | |
| 5.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 5.6% | 5.0% | 5.1% | 4.8% | 4.6% | 4.2% | 4.0% | 3.6% | 3.4% | 12.7% | 12.6% | 12.0% | |
| 2.3% | 2.0% | 2.0% | 1.8% | 1.8% | 1.6% | 1.5% | 1.3% | 1.2% | 8.7% | 13.4% | 12.3% | |
| 92.0% | 93.6% | 105.0% | 107.2% | 52.6% | 51.3% | 48.8% | 48.1% | 46.3% | 48.4% | 46.4% | 45.9% | |
| 47.6% | 47.6% | 44.3% | 42.6% | 43.4% | 42.8% | 40.5% | 39.4% | 38.0% | 39.4% | 36.8% | 36.6% | |
| 1.0% | 0.9% | 0.9% | 0.8% | 0.7% | 0.6% | 0.6% | 0.5% | 0.4% | 0.4% | 0.5% | 0.6% | |
| 1.7% | 1.6% | 1.3% | 1.2% | 1.2% | 1.6% | 1.4% | 1.3% | 1.3% | 1.8% | 1.1% | 1.8% | |
| 8.0% | 6.4% | -5.0% | -7.2% | 47.4% | 48.7% | 51.2% | 51.9% | 53.7% | 51.6% | 53.6% | 54.1% | |
| 27.8% | 22.2% | 8.8% | 4.1% | -29.3% | -23.9% | -20.8% | -16.3% | -12.9% | -9.2% | -7.9% | -7.0% | |
| 42.9% | 36.5% | 37.2% | 35.7% | 33.2% | 35.8% | 35.1% | 31.6% | 29.9% | 26.8% | 26.5% | 25.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.